1. Home
  2. CXAI vs UBX Comparison

CXAI vs UBX Comparison

Compare CXAI & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXAI
  • UBX
  • Stock Information
  • Founded
  • CXAI N/A
  • UBX 2009
  • Country
  • CXAI United States
  • UBX United States
  • Employees
  • CXAI N/A
  • UBX N/A
  • Industry
  • CXAI EDP Services
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXAI Technology
  • UBX Health Care
  • Exchange
  • CXAI Nasdaq
  • UBX Nasdaq
  • Market Cap
  • CXAI 33.9M
  • UBX 38.6M
  • IPO Year
  • CXAI N/A
  • UBX 2018
  • Fundamental
  • Price
  • CXAI $1.61
  • UBX $2.10
  • Analyst Decision
  • CXAI
  • UBX Strong Buy
  • Analyst Count
  • CXAI 0
  • UBX 2
  • Target Price
  • CXAI N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • CXAI 922.5K
  • UBX 369.6K
  • Earning Date
  • CXAI 11-12-2024
  • UBX 11-04-2024
  • Dividend Yield
  • CXAI N/A
  • UBX N/A
  • EPS Growth
  • CXAI N/A
  • UBX N/A
  • EPS
  • CXAI N/A
  • UBX N/A
  • Revenue
  • CXAI $7,200,000.00
  • UBX N/A
  • Revenue This Year
  • CXAI $3.86
  • UBX N/A
  • Revenue Next Year
  • CXAI $100.00
  • UBX $33.62
  • P/E Ratio
  • CXAI N/A
  • UBX N/A
  • Revenue Growth
  • CXAI N/A
  • UBX N/A
  • 52 Week Low
  • CXAI $1.09
  • UBX $0.94
  • 52 Week High
  • CXAI $7.07
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CXAI 46.28
  • UBX 62.50
  • Support Level
  • CXAI $1.42
  • UBX $2.05
  • Resistance Level
  • CXAI $1.63
  • UBX $2.42
  • Average True Range (ATR)
  • CXAI 0.13
  • UBX 0.31
  • MACD
  • CXAI -0.01
  • UBX -0.01
  • Stochastic Oscillator
  • CXAI 31.15
  • UBX 41.67

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: